Vanda Pharmaceuticals | Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Agios Pharmaceuticals USD 41.27M 4.6M 2025-09
Akebia Therapeutics USD 25.74M 1.93M 2025-03
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Anika Therapeutics USD 12.91M 17.8M 2025-03
Arrowhead Research USD 46.02M 8.84M 2025-12
AstraZeneca USD 148M 4.86B 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Esperion Therapeutics USD 39.98M 4.21M 2024-09
Halozyme Therapeutics USD 37.53M 4.53M 2025-09
Heron Therapeutics USD 23.34M 4.18M 2024-09
Insmed USD 186.38M 109.94M 2025-09
J&J USD 6.75B 831M 2025-12
Lexicon Pharmaceuticals USD 39.19M 7.13M 2024-06
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
Merck USD 2.85B 215M 2025-12
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Moderna USD 268M 38M 2025-09
Novartis USD 3.3B 137M 2025-09
Pfizer USD 4.08B 894M 2025-12
PTC Therapeutics USD 84.05M 1.22M 2025-09
Puma Biotechnology USD 16.82M 8.15M 2024-09
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.75B 455M 2025-12
Takeda JPY 282.78B 29.23B 2025-12
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12
Veracyte USD 51.73M 5.91M 2025-09


Vanda Pharmaceuticals Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.